Eulàlia Puigdecanet Riubugent
Member of the Cancer Profiling Research Line
Email: eulalia.puigdecanet@umedicina.cat
ORCID: 0000-0001-6067-9332
Scientific Profile: URECERCA
Eulàlia Puigdecanet is a lecturer at the University of Vic-Central University of Catalonia (UVic-UCC). Her research focuses on molecular and genetic profiling in cancer.
Dr. Puigdecanet holds a degree in Biology (2003, Pompeu Fabra University (UPF)) and developed her PhD on the characterization of haematopoietic diseases at molecular level using omics techniques together with routine diagnostic procedures (2012, Autonomous University of Barcelona (UAB)).
Her research career has been closely linked to genomics and molecular biology by performing translational research using high-throughtput technologies. She carried out her PhD research in a hospital setting at the Cytogenetics and Molecular Biology Laboratory of Hospital del Mar (Barcelona). Fom 2009 to 2019 she worked as Laboratory Responsible of the MARGenomics Service at the Hospital del Mar Medical Research Institute (IMIM).
In 2019, she joined UVic-UCC, where she lectures in Genetics and Physiology at the Faculty of Medicine. She also became a member of Institute for Research and Innovation in Life and Health Sciences in Central Catalonia (IRIS-CC), where she continues her research career.
My last happenings:
TR2Lab was present at the Spanish Society of Geriatric and Gerontological Nursing Congress
Recently, Dr. Marta Casals, member of TR2Lab, participated in the Congress of the Spanish Society of Geriatric and Gerontological Nursing (SEEGG), a leading scientific meeting for professionals dedicated to the care of older adults. As part of the scientific programme, Dr. Marta Casals presented an oral communication entitled “Translation, Cross-Cultural Adaptation and Validation of the Wound-QoL-17 Scale into Catalan.” The study aimed to provide a validated instrument for assessing the impact of chronic wounds on the quality of life of Catalan-speaking patients. The presentation described the translation and cultural adaptation process of the questionnaire, as well as the psychometric validation [...]
Molecular autopsy identifies the NaV1.5 p.Leu96Pro variant causing sodium current loss-of-function in unexplained sudden cardiac death
Authors: Albert Rigat Pujolasa, Rebecca Martínez-Moreno, David Carreras, Yajaira Alvarado-Cervantes, Elisabet Selga, Ramon Brugada, Guillermo J. Pérez, Fabiana S. Scornik Forensic Science International: Genetics, 86 (2027) 103587 DOI: 10.1016/j.fsigen.2026.103587 Read More Abstract Molecular autopsy can identify candidate variants in unexplained sudden cardiac death (SUD), but functional evidence is often required to support pathogenic interpretation and family risk assessment. Here, we investigated the functional consequences of the SCN5A c.287 T >C (NaV1.5_p.Leu96Pro) variant, identified in a 29-year-old man who died of SUD. Cascade screening identified additional relatives carrying the variant, with variable clinical expression. Sodium current (INa) was [...]
TR2Lab Joins Global Experts at the ERS International Congress 2026
Dr. Renata Da Palma, member of TR2Lab, participated in the ERS International Congress 2026 held in Barcelona, one of the world's largest and most influential meetings in respiratory medicine and science. During the event, she presented TR2Lab’s research on the anti-inflammatory effects of photobiomodulation therapy in an experimental model of asthma-COPD overlap. The congress brought together researchers, clinicians, and healthcare professionals from across the globe to share the latest advances in respiratory health, fostering scientific exchange and international collaboration. Scientific meetings such as ERS play an essential role in advancing research by facilitating knowledge sharing, promoting innovation, and creating new [...]
